Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis.
Wenting GuoJiali XuLinqing MaJin MaSijie LiChanghong RenLongfei WuChuanjie WuChuanhui LiJian ChenJiangang DuanQingfeng MaHaiqing SongWenbo ZhaoXun-Ming JiPublished in: CNS neuroscience & therapeutics (2022)
A low dose of tirofiban, regardless of their administration routes, was safe for AIS patients who achieved successful recanalization with EVT, whereas only IA + IV tirofiban improved clinical outcomes.